Longaeva Partners’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
Other funds holding IPSC
Longaeva Partners's IPSC Position: Q3 2026 in Review
Longaeva Partners opened a new position in Century Therapeutics (IPSC) in Q3 2026: 943,418 shares worth $1.61M. The stake represents 0.03% of the portfolio and ranks #256 among its holdings.
102 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.
- Longaeva Partners held 943,418 shares of Century Therapeutics worth $1.61M as of Q3 2026.
- Century Therapeutics was a new Longaeva Partners position in Q3 2026.
- Century Therapeutics made up 0.03% of Longaeva Partners's portfolio in Q3 2026, its #256 holding.
- 102 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.
Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.